1. Home
  2. CDNA vs PRG Comparison

CDNA vs PRG Comparison

Compare CDNA & PRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$45.88

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo PROG Holdings Inc.

PRG

PROG Holdings Inc.

HOLD

Current Price

$43.10

Market Cap

1.3B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDNA
PRG
Founded
1998
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Diversified Commercial Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
CDNA
PRG
Price
$45.88
$43.10
Analyst Decision
Buy
Buy
Analyst Count
6
5
Target Price
$28.00
$50.00
AVG Volume (30 Days)
1.3M
492.6K
Earning Date
04-28-2026
04-29-2026
Dividend Yield
N/A
1.45%
EPS Growth
N/A
N/A
EPS
2.13
1.80
Revenue
$48,324,000.00
$2,409,223,000.00
Revenue This Year
$16.01
$23.77
Revenue Next Year
$11.31
$7.91
P/E Ratio
$21.04
$24.13
Revenue Growth
18.93
N/A
52 Week Low
$11.27
$25.80
52 Week High
$49.76
$47.73

Technical Indicators

Market Signals
Indicator
CDNA
PRG
Relative Strength Index (RSI) 71.17 48.51
Support Level $16.70 $41.60
Resistance Level N/A $47.67
Average True Range (ATR) 2.18 1.86
MACD 0.61 -0.24
Stochastic Oscillator 66.44 40.50

Price Performance

Historical Comparison
CDNA
PRG

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About PRG PROG Holdings Inc.

PROG Holdings Inc is a financial technology holding company that provides transparent and competitive payment options to consumers. The company has two reportable segments: Progressive Leasing, an in-store, app-based, and e-commerce point-of-sale lease-to-own solutions provider; and Vive Financial (Vive), an omnichannel provider of second-look revolving credit products. The majority of the revenue of the company is earned through the Progressive Leasing segment.

Share on Social Networks: